{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:43:17Z","timestamp":1791830597897,"version":"4.3.4"},"reference-count":40,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"unspecified","delay-in-days":78,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Neurol Open"],"accepted":{"date-parts":[[2025,8,30]]},"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Duchenne muscular dystrophy (DMD) is a rare X-linked recessive disorder characterised by progressive muscle degeneration leading to severe disability and early mortality, with no cure. This disease process affects nearly every aspect of daily functioning, from basic movements to respiratory and cardiac functions, and consequently imposes a significant burden on patients, caregivers and families. We aimed to review the available literature examining the epidemiological, health-related quality of life (HRQoL) and economic burden of DMD in Australia from a societal perspective.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This scoping review was conducted by searching Embase and PubMed databases up until 22 August 2024. Two independent reviewers screened titles, abstracts and full texts. Studies that evaluated the epidemiological, HRQoL-related or economic burden of DMD in an Australian-specific context were included.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We identified 169 articles and assessed the full text of 32, of which nine were included in the review. Eight studies were observational with one theoretical\/computational study. Four studies addressed the epidemiological burden, estimating a birth prevalence of 18.6 to 22.7 DMD cases per 100\u2009000 male live births. Another four studies examined the HRQoL-related burden with three generic patient-reported outcome measures (PROMs) used to assess HRQoL. Two PROMs indicated lower self-reported and parent proxy HRQoL scores in boys with DMD compared with the general population, and the other PROM evaluated parental\/caregiver HRQoL. One study detailed the economic burden in 104 households, reporting significant annual socioeconomic burden of DMD associated with high levels of healthcare costs, non-medical resource use and caregiving burden to households.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Although the data estimating the epidemiological, HRQoL-related and economic burden of DMD in Australia is limited, existing evidence demonstrates a considerable societal burden of DMD. In the context of emerging disease-modifying therapies for DMD, it provides a summary of existing local evidence and research gaps, highlighting a need for further research.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjno-2025-001230","type":"journal-article","created":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T04:55:18Z","timestamp":1758171318000},"page":"e001230","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Burden of Duchenne muscular dystrophy in Australia: a scoping review"],"prefix":"10.1136","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-3041-4100","authenticated-orcid":false,"given":"Eugene","family":"Lee","sequence":"first","affiliation":[{"name":"Griffith University School of Medicine and Dentistry, Gold Coast, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seulki","family":"Choi","sequence":"additional","affiliation":[{"name":"Griffith University School of Medicine and Dentistry, Gold Coast, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hansoo","family":"Kim","sequence":"additional","affiliation":[{"name":"Griffith University School of Medicine and Dentistry, Gold Coast, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,9,17]]},"reference":[{"key":"2025091721551095000_7.2.e001230.1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00248-3"},{"key":"2025091721551095000_7.2.e001230.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2013.09.036"},{"key":"2025091721551095000_7.2.e001230.3","doi-asserted-by":"publisher","DOI":"10.1016\/0960-8966(91)90039-U"},{"key":"2025091721551095000_7.2.e001230.4","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-020-01430-8","article-title":"Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis","volume":"15","author":"Crisafulli","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"2025091721551095000_7.2.e001230.5","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-021-01862-w","article-title":"The clinical course of Duchenne muscular dystrophy in the corticosteroid treatment era: a systematic literature review","volume":"16","author":"Szabo","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"2025091721551095000_7.2.e001230.6","doi-asserted-by":"publisher","DOI":"10.1002\/mus.26803"},{"key":"2025091721551095000_7.2.e001230.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-8966(02)00140-2"},{"key":"2025091721551095000_7.2.e001230.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)07815-7"},{"key":"2025091721551095000_7.2.e001230.9","first-page":"e2304","article-title":"Life Expectancy in Duchenne Muscular Dystrophy: Reproduced Individual Patient Data Meta-analysis","volume":"97","author":"Broomfield","year":"2021","journal-title":"Neurology (ECronicon)"},{"key":"2025091721551095000_7.2.e001230.10","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2014.20.4.327"},{"key":"2025091721551095000_7.2.e001230.11","doi-asserted-by":"publisher","DOI":"10.7326\/M18-0850"},{"key":"2025091721551095000_7.2.e001230.12","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1445-5994.1973.tb03967.x","article-title":"Pseudohypertrophic muscular dystrophy of childhood: an epidemiological survey in Victoria","volume":"3","author":"Lawrence","year":"1973","journal-title":"Aust N Z J Med"},{"key":"2025091721551095000_7.2.e001230.13","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.17.4.245"},{"key":"2025091721551095000_7.2.e001230.14","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/s41431-022-01138-2","article-title":"Incidence of Duchenne muscular dystrophy in the modern era; an Australian study","volume":"30","author":"Kariyawasam","year":"2022","journal-title":"Eur J Hum Genet"},{"key":"2025091721551095000_7.2.e001230.15","article-title":"Determinants of the incidence of Duchenne muscular dystrophy","volume":"3","author":"Stark","year":"2015","journal-title":"Ann Transl Med"},{"key":"2025091721551095000_7.2.e001230.16","doi-asserted-by":"publisher","DOI":"10.1177\/0883073809357624"},{"key":"2025091721551095000_7.2.e001230.17","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1440-1754.2011.02022.x","article-title":"Health status of boys with Duchenne muscular dystrophy: A parent\u2019s perspective","volume":"47","author":"Bray","year":"2011","journal-title":"J Paediatrics Child Health"},{"key":"2025091721551095000_7.2.e001230.18","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s11136-016-1442-z","article-title":"Can in-the-moment diary methods measure health-related quality of life in Duchenne muscular dystrophy?","volume":"26","author":"Bray","year":"2017","journal-title":"Qual Life Res"},{"key":"2025091721551095000_7.2.e001230.19","article-title":"Newborn screening for Duchenne muscular dystrophy: the perspectives of stakeholders","volume":"45","author":"Ji","year":"2024","journal-title":"Lancet Reg Health West Pac"},{"key":"2025091721551095000_7.2.e001230.20","doi-asserted-by":"publisher","DOI":"10.1002\/mus.24965"},{"key":"2025091721551095000_7.2.e001230.21","doi-asserted-by":"publisher","DOI":"10.1038\/jhg.2013.119"},{"key":"2025091721551095000_7.2.e001230.22","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/BF00210802","article-title":"Segregation analysis of 1885 DMD families: significant departure from the expected proportion of sporadic cases","volume":"84","author":"Barbujani","year":"1990","journal-title":"Hum Genet"},{"key":"2025091721551095000_7.2.e001230.23","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1399-0004.1996.tb02383.x","article-title":"High frequency of new mutations in North Indian Duchenne\/Becker muscular dystrophy patients","volume":"50","author":"Sinha","year":"1996","journal-title":"Clin Genet"},{"key":"2025091721551095000_7.2.e001230.24","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2350-14-29","article-title":"MLPA-based genotype-phenotype analysis in 1053 Chinese patients with DMD\/BMD","volume":"14","author":"Yang","year":"2013","journal-title":"BMC Med Genet"},{"key":"2025091721551095000_7.2.e001230.25","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-023-03558-z"},{"key":"2025091721551095000_7.2.e001230.26","doi-asserted-by":"crossref","DOI":"10.1186\/s12955-016-0537-0","article-title":"Health-related quality of life measured using the EQ-5D-5L: South Australian population norms","volume":"14","author":"McCaffrey","year":"2016","journal-title":"Health Qual Life Outcomes"},{"key":"2025091721551095000_7.2.e001230.27","doi-asserted-by":"crossref","DOI":"10.2217\/fnl-2022-0004","article-title":"Using the EQ-5D to measure caregiver health-related quality of life in rare pediatric disease: a study in aromatic L-amino acid decarboxylase deficiency","volume":"17","author":"Acaster","year":"2022","journal-title":"Future Neurol"},{"key":"2025091721551095000_7.2.e001230.28","doi-asserted-by":"crossref","DOI":"10.1186\/s12955-020-01511-z","article-title":"Measuring quality of life in Duchenne muscular dystrophy: a systematic review of the content and structural validity of commonly used instruments","volume":"18","author":"Powell","year":"2020","journal-title":"Health Qual Life Outcomes"},{"key":"2025091721551095000_7.2.e001230.29","doi-asserted-by":"crossref","DOI":"10.1186\/s12955-022-01964-4","article-title":"Measuring carer quality of life in Duchenne muscular dystrophy: a systematic review of the reliability and validity of self-report instruments using COSMIN","volume":"20","author":"Carlton","year":"2022","journal-title":"Health Qual Life Outcomes"},{"key":"2025091721551095000_7.2.e001230.30","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X20978390"},{"key":"2025091721551095000_7.2.e001230.31","doi-asserted-by":"publisher","DOI":"10.1007\/s40258-023-00836-2"},{"key":"2025091721551095000_7.2.e001230.32","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.jval.2021.05.016","article-title":"Rasch Analysis of the Pediatric Quality of Life Inventory 4.0 Generic Core Scales Administered to Patients With Duchenne Muscular Dystrophy","volume":"24","author":"Landfeldt","year":"2021","journal-title":"Value Health"},{"key":"2025091721551095000_7.2.e001230.33","first-page":"e2438","article-title":"Development of a New Quality of Life Measure for Duchenne Muscular Dystrophy Using Mixed Methods: The DMD-QoL","volume":"96","author":"Powell","year":"2021","journal-title":"Neurology (ECronicon)"},{"key":"2025091721551095000_7.2.e001230.34","unstructured":"Australian Government, Australian Institute of Health and Welfare . Health expenditure australia 2022\u201323 \u2013 the health sector relative to the economy \u2013 health prices. 2024. Available: https:\/\/www.aihw.gov.au\/reports\/health-welfare-expenditure\/health-expenditure-australia-2022 [Accessed 5 Jan 2025]."},{"key":"2025091721551095000_7.2.e001230.35","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1212\/WNL.0000000000000669","article-title":"The burden of Duchenne muscular dystrophy: an international, cross-sectional study","volume":"83","author":"Landfeldt","year":"2014","journal-title":"Neurology (ECronicon)"},{"key":"2025091721551095000_7.2.e001230.36","unstructured":"Australian Government, Australian Institute of Health and Welfare . Informal carers. 2023. Available: https:\/\/www.aihw.gov.au\/reports\/australias-welfare\/informal-carers [Accessed 5 Jan 2025]."},{"key":"2025091721551095000_7.2.e001230.37","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1016\/S2468-2667(23)00299-2","article-title":"The effect of informal caring on mental health among adolescents and young adults in Australia: a population-based longitudinal study","volume":"9","author":"Fleitas Alfonzo","year":"2024","journal-title":"Lancet Public Health"},{"key":"2025091721551095000_7.2.e001230.38","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.vhri.2022.08.006","article-title":"Estimating Societal Cost of Illness and Patients\u2019 Quality of Life of Duchenne Muscular Dystrophy in Egypt","volume":"33","author":"Shehata","year":"2023","journal-title":"Value Health Reg Issues"},{"key":"2025091721551095000_7.2.e001230.39","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-014-0210-9","article-title":"Comparative cost of illness analysis and assessment of health care burden of Duchenne and Becker muscular dystrophies in Germany","volume":"9","author":"Schreiber-Katz","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"2025091721551095000_7.2.e001230.40","doi-asserted-by":"publisher","DOI":"10.1007\/s41669-023-00450-x"}],"container-title":["BMJ Neurology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjno-2025-001230","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T04:55:24Z","timestamp":1758171324000},"score":1,"resource":{"primary":{"URL":"https:\/\/neurologyopen.bmj.com\/lookup\/doi\/10.1136\/bmjno-2025-001230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":40,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,9,17]]},"published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1136\/bmjno-2025-001230"],"URL":"https:\/\/doi.org\/10.1136\/bmjno-2025-001230","relation":{},"ISSN":["2632-6140"],"issn-type":[{"value":"2632-6140","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}